Scripta Insight

About Scripta Insight

Scripta Insights is a healthcare information technology company providing a pharmacy navigation platform that helps lower prescription drug costs for self-insured employers, health plans, and their members. The company was co-founded in 2019 by CEO Eric Levin and Chief Medical Officer Dr. Paul S. Bradley. Dr. Bradley was inspired to start the company due to his frustration with patients being unable to afford medications he prescribed. Realizing that physicians often lack insight into drug pricing, he and his wife assembled a team of doctors to identify prescription savings, which laid the groundwork for the company. Eric Levin, a serial entrepreneur with a history of growing and selling major companies, joined Dr. Bradley to address the prescription drug affordability crisis.

The company's core technology, Script.AI, uses artificial intelligence and data analytics to analyze millions of pharmacy transactions, identify savings opportunities, and provide transparency in the pharmacy benefits market. Scripta's solutions work with a client's existing Pharmacy Benefit Manager (PBM) to contain costs. It serves self-insured employers, payers, Third Party Administrators (TPAs), and health plans. The business model is centered on providing software-enabled pharmacy cost containment solutions through both an enterprise B2B offering and a direct member benefit. Scripta offers two main products: Rx Navigator for members and Rx Monitor for plan sponsors. Rx Navigator provides members with personalized savings reports via a mobile app, web portal, or mail, showing all their prescription options and ways to save. Rx Monitor provides plan sponsors with analytics and insights to manage and monitor their pharmacy benefit expenses. The company also partners with other entities, like RxSaveCard and Lightbeam Health Solutions, to expand its cost-saving capabilities.

Scripta Insights has achieved significant growth and secured substantial funding, including a Series B round that brought its total funding to over $42 million. This capital is being used to scale the platform within the self-insured market and expand into the health plan and Medicare Advantage markets.